| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.812 | 47.917 | 30.788 | 29.872 | 27.390 | 55.055 | 34.267 | 28.633 | 24.939 | 16.096 |
| Total Income - EUR | 11.313 | 49.252 | 31.623 | 31.518 | 28.819 | 55.753 | 36.704 | 29.994 | 25.323 | 17.119 |
| Total Expenses - EUR | 7.692 | 23.280 | 19.165 | 18.999 | 19.635 | 10.992 | 11.645 | 23.611 | 28.956 | 27.263 |
| Gross Profit/Loss - EUR | 3.621 | 25.972 | 12.458 | 12.519 | 9.184 | 44.761 | 25.059 | 6.383 | -3.634 | -10.144 |
| Net Profit/Loss - EUR | 3.282 | 24.494 | 11.509 | 11.574 | 8.751 | 43.089 | 23.958 | 5.737 | -3.887 | -10.315 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dan G&A Medconsulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 624 | 418 | 1.868 | 1.135 | 1.182 | 540 | 237 | 91 | 0 | 1.129 |
| Current Assets | 55.953 | 74.026 | 66.267 | 79.077 | 74.152 | 112.659 | 124.563 | 131.627 | 130.068 | 109.338 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 247 | 285 | 3.637 | 3.380 | 3.090 | 12.403 | 11.472 | 10.927 | 9.433 | 8.575 |
| Cash | 55.707 | 73.741 | 62.629 | 75.697 | 71.063 | 100.256 | 113.090 | 120.700 | 120.634 | 100.764 |
| Shareholders Funds | -7.212 | 45 | 44 | 46 | 45 | 44 | 46 | 5.783 | -3.841 | -14.135 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 63.790 | 74.398 | 68.090 | 80.166 | 75.290 | 113.154 | 124.754 | 125.935 | 133.909 | 124.602 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Dan G&A Medconsulting Srl